tiprankstipranks
aTyr Pharma (ATYR)
NASDAQ:ATYR
US Market

aTyr Pharma (ATYR) Income Statement

Compare
2,034 Followers

aTyr Pharma Income Statement

Last quarter (Q3 2024), aTyr Pharma's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, aTyr Pharma's net income was $-17.26M. See aTyr Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 353.00K$ 10.39M$ 0.00$ 10.46M$ 422.00K
Gross Profit
$ -2.39M$ 8.69M$ -1.30M$ -6.84M$ -13.63M
Operating Expenses
$ 55.27M$ 55.09M$ 32.71M$ 25.10M$ 22.03M
Depreciation and Amortization
$ 2.74M$ 1.70M$ 1.30M$ 1.27M$ 1.37M
EBITDA
$ -52.18M$ -44.71M$ -32.47M$ -14.64M$ -21.61M
Operating Income
$ -54.92M$ -46.40M$ -34.02M$ -15.91M$ -22.98M
Other Income/Expenses
$ 4.52M$ 1.06M$ 238.00K$ -319.00K$ -785.00K
Pretax Income
$ -50.40M$ -45.34M$ -33.78M$ -16.23M$ -23.76M
Net Income
$ -50.39M$ -45.34M$ -33.77M$ -16.22M$ -23.60M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.94$ -1.60$ -1.77$ -1.77$ -7.03
Diluted EPS
$ -0.94$ -1.60$ -1.77$ -1.77$ -7.03
Weighted Average Shares Outstanding
53.61M 28.42M 19.08M 9.16M 3.36M
Weighted Average Shares Outstanding (Diluted)
53.61M 28.42M 19.08M 9.16M 3.36M
Currency in USD

aTyr Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis